Sensorineural hearing loss

Enhancing Genetic Discovery in Sensorineural Hearing Loss Through Precision Audiometric Phenotyping

By MedXY 10/19/2026

Precision phenotyping using audiometric pure-tone averages enhances genetic variant detection for sensorineural hearing loss compared to diagnostic coding, offering improved heritability estimates and risk prediction to advance hearing health precision medicine.

news Otorhinolaryngology Pediatrics

Expanding Pediatric Cochlear Implant Indications: Multicenter Evidence Supports Safety and Efficacy in Younger Children and Those with Residual Hearing

By MedXY 08/21/2026

A multicenter study demonstrates the safety and effectiveness of MED-EL cochlear implants in children under 12 months and in 12-71 month-olds with residual hearing, supporting expanded pediatric CI candidacy.

news Otorhinolaryngology

NLRP3 Inflammasome in Hearing Loss: Mechanisms and Emerging Therapeutic Strategies

By MedXY 11/04/2025

The NLRP3 inflammasome plays a central role in inflammation-mediated sensorineural hearing loss (SNHL). Genetic and acquired activation causes cochlear damage through cytokine release and pyroptosis. Targeted therapies, including IL-1 blockers and novel NLRP3 inhibitors, offer hope for effective treatment of various SNHL forms.